Chubb partners with Verified Clinical Trials

Verified Clinical Trials (VCT), a provider of clinical trial subject registry solutions, announced a strategic alliance with Chubb focused on reducing risks tied to duplicate enrollment and protocol violations in clinical trials.

VCT’s technology is designed to detect overlapping study participation and other screening issues that can impact patient safety, data quality, and study integrity. Under the alliance, Chubb clients will gain access to VCT’s registry capabilities as part of a broader clinical trial risk management approach.

The partnership supports efforts to improve protocol compliance and reduce operational, regulatory, and liability risks for sponsors, CROs, and research sites.

“Research subject safety and data integrity are fundamental to every successful clinical trial. This alliance with Chubb represents an important opportunity to help bring greater protection, stronger oversight, and added value to the clinical research ecosystem. Ultimately, the broader public stands to benefit as well, as safer, more effective drugs and therapies can be developed and brought forward with greater confidence for patient use.” – Dr. Mitchell Efros, Co-Founder & CEO at Verified Clinical Trials.

“Chubb is committed to supporting innovative and practical approaches to risk management in clinical research. VCT addresses a longstanding and underrecognized challenge in clinical research: the inability to reliably look into a participant’s research history to confirm eligibility. This alliance with VCT reflects a shared focus on improving research subject safety, study integrity, and overall trial performance.” – Lee Farrow, EVP, Life Sciences Industry Practice Leader at Chubb.